Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SOLYSTAT PENDOPHARM DIVISION OF PHARMASCIENCE INC Actual shortage 250MG Updated Report 2025-12-23 274875
OTIXAL MEDEXUS PHARMACEUTICALS INC. Actual shortage 0.3% 0.025% Updated Report 2025-12-23 274572
MYLAN-VALACYCLOVIR MYLAN PHARMACEUTICALS ULC Actual shortage 1000MG Updated Report 2025-12-23 273002
ETOMIDATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 2MG Updated Report 2025-12-23 273806
DEXAMETHASONE OMEGA UNIDOSE OMEGA LABORATORIES LIMITED Actual shortage 10MG Updated Report 2025-12-23 274514
ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Anticipated shortage 2MG Updated Report 2025-12-22 274903
ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Anticipated shortage 2MG Updated Report 2025-12-22 274900
DEXAMETHASONE-OMEGA OMEGA LABORATORIES LIMITED Actual shortage 4MG Updated Report 2025-12-22 272781
JAMP-SIMVASTATIN JAMP PHARMA CORPORATION Actual shortage 20MG Updated Report 2025-12-22 267597
!T3 IFEX BAXTER CORPORATION Anticipated shortage 1G Updated Report 2025-12-22 273126

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
EMERADE BAUSCH HEALTH, CANADA INC. Discontinued 0.3MG Updated Report 2025-12-20 274742
EMERADE BAUSCH HEALTH, CANADA INC. Discontinued 0.5MG Updated Report 2025-12-20 274745
DILANTIN-30 SUSPENSION BGP PHARMA ULC Discontinued 30MG New Report 2025-12-19 274803
DILANTIN-125 SUSPENSION BGP PHARMA ULC Discontinued 125MG New Report 2025-12-19 274800
GRAVOL IM CHURCH & DWIGHT CANADA CORP Discontinued 50MG Updated Report 2025-12-19 274712